K. Nedrow

Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population

K. Simpson, R. Chambers, S. Snedecor, 2014, PloS one.

HIV economic burden of illness in the Veterans Health Administration population

K. Simpson, O. Baser, Li Wang, 2015, AIDS care.

A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.

M. Azadniv, J. Liesveld, M. Becker, 2021, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

K. Simpson, J. Stephens, C. Craig, 2014, AIDS Research and Human Retroviruses.

The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients

J. Stephens, R. Chambers, S. Snedecor, 2013, PloS one.

Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors

C. Pashos, L. Boulanger, K. Simpson, 2014, HIV medicine.

AIDS Care : Psychological and Socio-medical Aspects of AIDS / HIV

O. Baser, K. N. Simpson, Li Wang, 2014 .

Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis.

K. Simpson, J. Stephens, C. Craig, 2014, AIDS research and human retroviruses.

Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4.

R. Gillilan, N. Noy, S. Ayers, 2007, Biochemistry.